12th Mar 2014 11:33
LONDON (Alliance News) - Allergy Therapeutics PLC Wednesday reported revenues of GBP40.5 million and a profit of GBP890,000 for the 12 months to September 30, 2013.
The company's financial year runs until the end of June, but it has provided additional figures for the year to end-September for including in the annual report of its largest shareholder, CFR Pharmaceutical SA.
Last September, it had reported a net profit of GBP536,000 for the year to end-June, 2013, down from GBP823,000 in fiscal 2012, as revenues fell to GBP39.3 million from GBP41.3 million, mainly due to foreign exchange moves.
Allergy Therapeutics shares were down 2.5% at 25.6 pence Wednesday morning.
By Steve McGrath; [email protected]; @SteveMcGrath1
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Allergy Thera.